PPA
BNR

Parametric Portfolio Associates’s Burning Rock Biotech BNR Stock Holding History

Parametric Portfolio Associates’s Portfolio BNR Stock Details BNR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-8,024
Closed -$1.44M – 3643
2021
Q3 		$1.44M Sell
8,024
-1,282
-14% -$285K ﹤0.01% 2629
2021
Q2 		$2.74M Buy
9,306
+8,255
+785% +$2.44M ﹤0.01% 2253
2021
Q1 		$283K Hold
1,051
– – ﹤0.01% 3739
2020
Q4 		$243K Hold
1,051
– – ﹤0.01% 3689
2020
Q3 		$263K Buy
+1,051
New +$249K ﹤0.01% 3540

Other funds holding BNR

Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
MICM
Matthews International Capital Management San Francisco, California $292M AUM 75.01% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Canada Pension Plan Investment Board
Canada Pension Plan Investment Board Toronto Ontario, Ontario, Canada $181B AUM 41.77% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Parametric Portfolio Associates's BNR Position: Q4 2021 in Review

Parametric Portfolio Associates sold out of Burning Rock Biotech (BNR) in Q4 2021, closing a stake of 8,024 shares — an estimated $1.44M sold.

Parametric Portfolio Associates first reported a position in BNR in Q3 2020 and held it in 5 quarters. The position peaked at $2.74M in Q2 2021. 62 funds tracked by Wall St. Rank hold BNR as of Q4 2021.

  • Parametric Portfolio Associates reported no remaining Burning Rock Biotech position as of Q4 2021 after selling out during the quarter.
  • Parametric Portfolio Associates sold 8,024 Burning Rock Biotech shares in Q4 2021, an estimated $1.44M.
  • Parametric Portfolio Associates first reported a position in Burning Rock Biotech in Q3 2020 and held it in 5 quarters.
  • Parametric Portfolio Associates's Burning Rock Biotech position peaked at $2.74M in Q2 2021.
  • 62 funds tracked by Wall St. Rank held Burning Rock Biotech as of Q4 2021.

Based on Parametric Portfolio Associates's 13F filing for Q4 2021, filed 15 Feb 2022.